Korean Circulation Journal

The Korean Society of Cardiology (대한심장학회)
권호 표지
DOI QR코드

DOI QR Code

Can Artemisinin Be a Game Changer Even as an Antiarrhythmic Drug?

  • Jongmin Hwang (Division of Cardiology, Department of Internal Medicine, Keimyung University Dongsan Hospital)
  • Received : 2023.02.21
  • Accepted : 2023.02.26
  • Published : 2023.04.01
Download PDF
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Zeppenfeld K, Tfelt-Hansen J, de Riva M, et al. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J 2022;43:3997-4126.
  2. Talib AK, Nogami A. Catheter ablation for Brugada syndrome. Korean Circ J 2020;50:289-301.
  3. Campbell T, Bennett RG, Kotake Y, Kumar S. Updates in ventricular tachycardia ablation. Korean Circ J 2021;51:15-42.
  4. Tu Y. The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine. Nat Med 2011;17:1217-20.
  5. Wang J, Xu C, Wong YK, et al. Artemisinin, the magic drug discovered from traditional Chinese medicine. Engineering (Beijing) 2019;5:32-9.
  6. Jang S, Jeong MH, Lim KS, et al. Effect of stents coated with artemisinin or dihydroartemisinin in a porcine coronary restenosis model. Korean Circ J 2017;47:115-22.
  7. Jeong HK, Hong SN, Yoon N, Lee KH, Park HW, Cho JG. Antiarrhythmic effect of artemisinin in an ex-vivo model of Brugada syndrome induced by NS5806. Korean Circ J 2023;53:239-50.
  8. Saadeh K, Nantha Kumar N, Fazmin IT, Edling CE, Jeevaratnam K. Anti-malarial drugs: mechanisms underlying their proarrhythmic effects. Br J Pharmacol 2022;179:5237-58.
  9. Kim D, Yang PS, Joung B. Optimal rhythm control strategy in patients with atrial fibrillation. Korean Circ J 2022;52:496-512.